|
REL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.12380000036627E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73408999999403E-05 |
| Normal-vs-Stage2 |
7.9786999995779E-07 |
| Normal-vs-Stage3 |
3.55810000000067E-05 |
| Normal-vs-Stage4 |
3.199200E-03 |
| Stage1-vs-Stage2 |
4.752500E-02 |
| Stage1-vs-Stage3 |
6.578600E-01 |
| Stage1-vs-Stage4 |
7.258400E-01 |
| Stage2-vs-Stage3 |
1.103620E-01 |
| Stage2-vs-Stage4 |
5.120500E-02 |
| Stage3-vs-Stage4 |
5.246200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.97700000000145E-05 |
| Normal-vs-AfricanAmerican |
7.572300E-02 |
| Normal-vs-Asian |
4.031700E-04 |
| Caucasian-vs-AfricanAmerican |
5.490600E-01 |
| Caucasian-vs-Asian |
5.004400E-01 |
| AfricanAmerican-vs-Asian |
3.328400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07080000000259E-06 |
| Normal-vs-Female |
1.96377999999164E-05 |
| Male-vs-Female |
2.461800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.638600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.56241000000001E-05 |
| Normal-vs-Age(61-80Yrs) |
1.57024999999367E-05 |
| Normal-vs-Age(81-100Yrs) |
5.798200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.964000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.605900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.603400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.978800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.057400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.954600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.120600E-01 |
| Classical-VS-Follicular |
1.65267799445701E-12 |
| Classical-VS-Other |
3.844700E-03 |
| Classical-VS-Normal |
5.046200E-04 |
| Tall-VS-Follicular |
4.773500E-04 |
| Tall-VS-Other |
1.152390E-02 |
| Tall-VS-Normal |
1.726350E-02 |
| Follicular-VS-Other |
8.972200E-01 |
| Follicular-VS-Normal |
1.98900007575276E-10 |
| Other-VS-Normal |
1.67747999999524E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.50510000018755E-07 |
| Normal-vs-N1 |
3.058500E-02 |
| N0-vs-N1 |
6.821700E-03 |
|
|
